[go: up one dir, main page]

MX2019008393A - Composicion para prevenir infeccion por mycoplasma spp. - Google Patents

Composicion para prevenir infeccion por mycoplasma spp.

Info

Publication number
MX2019008393A
MX2019008393A MX2019008393A MX2019008393A MX2019008393A MX 2019008393 A MX2019008393 A MX 2019008393A MX 2019008393 A MX2019008393 A MX 2019008393A MX 2019008393 A MX2019008393 A MX 2019008393A MX 2019008393 A MX2019008393 A MX 2019008393A
Authority
MX
Mexico
Prior art keywords
composition
prevent infection
mycoplasma spp
vaccine
protein
Prior art date
Application number
MX2019008393A
Other languages
English (en)
Other versions
MX382924B (es
Inventor
Perng WANG Jyh-
Weng CHEN Zeng-
Yu Fang Chien-
Wei HSIEH Ming-
Cheng Yang Ping-
Horng Lin Jiunn-
Original Assignee
Agricultural Tech Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Tech Res Inst filed Critical Agricultural Tech Res Inst
Publication of MX2019008393A publication Critical patent/MX2019008393A/es
Publication of MX382924B publication Critical patent/MX382924B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporciona proteina usada como un ingrediente activo de una vacuna de subunidad contra mycoplasma y la vacuna preparada de la misma; la vacuna comprende P46, Tuf o proteina compuesta del mismo y puede comprender adicionalmente MHP30, NrdFC o proteína compuesta de los mismos.
MX2019008393A 2013-11-21 2013-11-21 Composición para prevenir infección por mycoplasma spp. MX382924B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/087599 WO2015074213A1 (zh) 2013-11-21 2013-11-21 防治霉浆菌感染的组合物

Publications (2)

Publication Number Publication Date
MX2019008393A true MX2019008393A (es) 2019-09-16
MX382924B MX382924B (es) 2025-03-13

Family

ID=53178807

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019008393A MX382924B (es) 2013-11-21 2013-11-21 Composición para prevenir infección por mycoplasma spp.
MX2016006643A MX368864B (es) 2013-11-21 2013-11-21 Composicion para prevenir infeccion por mycoplasma spp.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2016006643A MX368864B (es) 2013-11-21 2013-11-21 Composicion para prevenir infeccion por mycoplasma spp.

Country Status (14)

Country Link
US (2) US9951109B2 (es)
EP (1) EP3072523B1 (es)
JP (1) JP6434017B2 (es)
KR (1) KR101842081B1 (es)
CN (2) CN105792841B (es)
BR (1) BR112016010427B1 (es)
DK (1) DK3072523T3 (es)
ES (1) ES2714000T3 (es)
MX (2) MX382924B (es)
PH (1) PH12016500946A1 (es)
RU (1) RU2646137C2 (es)
TW (1) TWI615402B (es)
UA (1) UA116697C2 (es)
WO (1) WO2015074213A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3072523B1 (en) * 2013-11-21 2018-12-26 Agricultural Technology Research Institute Composition for preventing and curing mycoplasma infection
TWI606839B (zh) * 2016-08-09 2017-12-01 財團法人農業科技研究院 防治豬鼻黴漿菌感染之組合物及生產該組合物的方法
KR102251603B1 (ko) * 2016-08-09 2021-05-14 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 마이코플라즈마 하이오라이니스 감염의 예방 및 치료용 조성물 및 조성물의 생산 방법
US11253581B2 (en) 2017-11-01 2022-02-22 Agricultural Technology Research Institute Composition for preventing or treating Mycoplasma synoviae infection
CN110904138A (zh) * 2018-09-17 2020-03-24 杭州博茵生物技术有限公司 一种Msyb融合标签的大肠杆菌可溶性蛋白表达载体、构建方法及应用
CN112485423A (zh) * 2020-11-16 2021-03-12 江苏省农业科学院 一种通用的猪支原体抗原含量快速检测试剂盒及其应用
CN114853910B (zh) * 2022-05-19 2025-02-07 福建省农业科学院畜牧兽医研究所 一种具有免疫原性的绵羊肺炎支原体hsp70-p113融合蛋白
WO2025050285A1 (zh) * 2023-09-05 2025-03-13 财团法人农业科技研究院 防治猪鼻霉浆菌感染的组合物及其制造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475185A1 (en) * 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
JPH06172213A (ja) * 1992-05-31 1994-06-21 Uen Chun-Nan マイコプラズマ肺炎用ワクチン
AU6128900A (en) 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
CA2340455A1 (en) * 2001-03-28 2002-09-28 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
MXPA03011924A (es) 2001-07-02 2004-03-26 Pfizer Prod Inc Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
DK2027873T3 (en) 2001-07-02 2015-11-09 Zoetis Services Llc Single Dose Vaccination with Mycoplasma hyopneumoniae
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
JP2006311824A (ja) * 2005-05-09 2006-11-16 National Agriculture & Food Research Organization 豚マイコプラズマ肺炎ワクチン
CN102732473B (zh) * 2011-04-08 2017-03-15 华中农业大学 表达猪肺炎支原体p46蛋白的重组猪霍乱沙门氏菌及制备方法与应用
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
EP3733691A1 (en) * 2013-02-05 2020-11-04 Agricultural Technology Research Institute Anti-mycoplasma spp. subunit vaccine
EP3072523B1 (en) * 2013-11-21 2018-12-26 Agricultural Technology Research Institute Composition for preventing and curing mycoplasma infection

Also Published As

Publication number Publication date
BR112016010427A2 (pt) 2017-12-05
RU2016123841A (ru) 2017-12-26
TWI615402B (zh) 2018-02-21
TW201520222A (zh) 2015-06-01
WO2015074213A8 (zh) 2016-05-19
EP3072523A1 (en) 2016-09-28
US20180208629A1 (en) 2018-07-26
US9951109B2 (en) 2018-04-24
RU2646137C2 (ru) 2018-03-01
CN105792841A (zh) 2016-07-20
DK3072523T3 (en) 2019-04-08
KR20160060771A (ko) 2016-05-30
UA116697C2 (uk) 2018-04-25
US20160264631A1 (en) 2016-09-15
BR112016010427B1 (pt) 2020-06-02
JP2016538846A (ja) 2016-12-15
MX382924B (es) 2025-03-13
MX368864B (es) 2019-10-18
KR101842081B1 (ko) 2018-03-26
JP6434017B2 (ja) 2018-12-05
CN110302368B (zh) 2022-11-04
EP3072523B1 (en) 2018-12-26
CN105792841B (zh) 2019-07-26
WO2015074213A1 (zh) 2015-05-28
ES2714000T3 (es) 2019-05-24
EP3072523A4 (en) 2017-05-03
CN110302368A (zh) 2019-10-08
PH12016500946A1 (en) 2016-06-27
MX2016006643A (es) 2017-01-16
US10059749B2 (en) 2018-08-28

Similar Documents

Publication Publication Date Title
MX2019008393A (es) Composicion para prevenir infeccion por mycoplasma spp.
NI201700011A (es) 2-(morfolin-4-il)-1,7-naftiridinas.
MX2019005379A (es) Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo.
CR20170279A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
CL2016000106A1 (es) Sulfonamidas como moduladores de canales de sodio.
CL2014000956A1 (es) Compuestos derivados de (4-fenilimidazol-2-il)etilamina, como moduladores de canal de sodio; composicion farmaceutica que los comprende; y su uso en el tratamiento del dolor.
CL2016001120A1 (es) Compuestos derivados de pirrolo1,2-f1,2,4triazina ,composición farmacéutica que los comprende y su uso en el tratamiento de una infección por virus sincicial compuestos intermediarios. pct
MX2015009772A (es) Moduladores de receptores nmda de espiro-lactama y sus usos.
CR20150480A (es) Composición farmacéutica de clorhidrato de s-cetamina
CR20150481A (es) Composición farmacéutica de clorhidrato de s-ketamina
ECSP18010481A (es) Composiciones de plinabulina
MX2018003294A (es) Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias.
CL2015001562A1 (es) Método para obtener una vacuna de mycoplasma.
BR112015023161A8 (pt) derivados de piridin-4-ila
NI201700078A (es) Pirazolpiridinaminas
NI201600006A (es) Pirazolo-piridinaminas sustituidas
UY35848A (es) Tienopirimidinas
PE20190210A1 (es) Aplicaciones de carrimicina en la infeccion por micobacterium tuberculosis resistente
MX389026B (es) Una composicion farmaceutica y el uso de la misma.
GEP20237486B (en) Formulations of copanlisib
UY36045A (es) Formulaciones antihelmínticas veterinarias estables
PE20160596A1 (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana
CO6761349A2 (es) Proteína antimicrobiana
CO2018005491A2 (es) Formulación de combinación de dosis fija, eflornitina y sulindaco
BR112016012435A2 (pt) Vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2